|
Volumn 18, Issue 4, 2008, Pages 474-476
|
Cutaneous pseudolymphoma associated with a TNF-alpha inhibitor treatment: Etanercept
c
HÔPITAL NORD
(France)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
ETANERCEPT;
HLA DR ANTIGEN;
PREDNISONE;
TUMOR NECROSIS FACTOR ALPHA INHIBITOR;
ADULT;
B LYMPHOCYTE;
BLOOD CELL COUNT;
BONE DESTRUCTION;
CASE REPORT;
CLINICAL EXAMINATION;
DISEASE ACTIVITY;
DRUG EFFECT;
DRUG ERUPTION;
DRUG INDUCED DISEASE;
DRUG WITHDRAWAL;
ERYTHROCYTE SEDIMENTATION RATE;
FATIGUE;
FEMALE;
FEVER;
HUMAN;
IMMUNOASSAY;
IMMUNOHISTOCHEMISTRY;
LABORATORY TEST;
LETTER;
LYMPHOCYTIC INFILTRATION;
MONOTHERAPY;
PSEUDOLYMPHOMA;
RHEUMATOID ARTHRITIS;
SKIN BIOPSY;
SKIN LYMPHOMA;
T LYMPHOCYTE;
WRIST RADIOGRAPHY;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
HUMANS;
IMMUNOGLOBULIN G;
MALE;
MIDDLE AGED;
PSEUDOLYMPHOMA;
RECEPTORS, TUMOR NECROSIS FACTOR;
SKIN DISEASES;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 47749143566
PISSN: 11671122
EISSN: None
Source Type: Journal
DOI: 10.1684/ejd.2008.0457 Document Type: Letter |
Times cited : (22)
|
References (6)
|